To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Advent sees profit on Argentine drug exit
Boston-based Advent International has sold its stake in Argentine generic pharmaceuticals maker Fada Pharma, earning a positive return on the investment despite the volatile Argentine macro environment.
